A multifunctional targeted capsule with resistant starch as wall material

By using butyrylated resistant starch as a wall material, aspirin is wrapped by multifunctional targeted capsules to avoid direct contact with the gastrointestinal tract in the stomach, it solves the ulcer and colon cancer problems caused by long-term use of aspirin, and reduces side effects and enhances Effects of medicine.

CN117137879BActive Publication Date: 2024-11-26LUOHE MEDICAL COLLEGE
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202311194587.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-09-15
Publication Date
2024-11-26
Estimated Expiration
2043-09-15

AI Technical Summary

Technical Problem

The incidence of ulcers and colon cancer due to long-term direct contact with aspirin tract leads to a high level of incidence, and the prior art is difficult to effectively reduce its side effects.

Method used

Using a multifunctional targeted capsule with butyrylated resistant starch as the wall material, aspirin is wrapped in enteric-coated capsules to prevent it from directly contacting the gastrointestinal tract and indigestion and dissolving in the stomach until it reaches the colon part is broken down. After release, increase the number of short-chain fatty acids and probiotics and reduce intestinal pH.

Benefits of technology

Effectively reduce the side effects of aspirin, reduce the incidence of ulcer disease, reduce the incidence of colon cancer, and at the same time realize the efficacy of aspirin and improve the bioavailability of the drug.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
Patent Text Reader

Abstract

The present invention provides a multifunctional targeting capsule with resistant starch as wall material, wherein the capsule wall material is butyrylated resistant starch, and the core material is medical grade aspirin; the ingredient sol in the preparation of the capsule is: take 10 parts of butyrylated resistant starch, put the butyrylated resistant starch into 10 parts of ethanol solution, add 2-4 parts of plasticizer, 1.2-2.8 parts of gelling agent, 0.1-0.3 parts of coagulant and 70-90 parts of deionized water and stir and mix evenly, keep the temperature at 60-95°C, and sol for 1-3h. The butyrylated resistant starch is first mixed with ethanol and then with deionized water to dissolve the butyrylated resistant starch, and a suitable proportion of gelling agent carrageenan is selected to prepare a multifunctional targeting capsule. The present invention provides a multifunctional targeting capsule with resistant starch as wall material, which reduces the incidence of ulcers and colon cancer caused by direct contact of aspirin with the gastrointestinal tract.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of targeted capsules, and in particular to a multifunctional targeted capsule using resistant starch as a wall material. Background Art

[0002] Resistant starch, also known as resistant starch, is difficult to digest. It cannot be enzymatically hydrolyzed in the small intestine, but it can ferment with volatile fatty acids in the human gastrointestinal colon. The ability to produce short-chain fatty acids after fermentation is much higher than that of traditional dietary fiber. Resistant starch has low water retention and is mostly used to improve food processing technology. It can be used as a functional component of dietary fiber and added to food in appropriate amounts to make flavored foods and functional foods with different characteristics. After ingesting resistant starch, the corresponding short-chain fatty acids can be specifically increased, the structure of human intestinal flora can be changed, and the number of pathogenic flora can be reduced. At present, resistant starch is usually used in health foods and probiotics.

[0003] Hard capsules are made by adding a certain amount of medicinal extracts to powder or excipients to make uniform powder or granules, filling them in hollow capsules, or directly packing medicinal powder in hollow capsules. The process of hard capsules is relatively simple and easy to take. The drugs are placed in the capsule shell and isolated from the outside world, avoiding the influence of moisture, air, and light. They have a certain degree of shielding, protection, and stabilization for drugs with bad smell or instability. The bioavailability of drugs is high, and the release of drugs can be delayed and localized. For example, in medical applications, they can reduce the side effects of some drugs and increase the utilization of drugs. They have been widely used in recent years.

[0004] Aspirin is usually used as an antipyretic, analgesic, non-steroidal anti-inflammatory drug, and antiplatelet aggregation drug. After nearly a hundred years of clinical application, it has been proven that aspirin is effective in relieving mild or moderate pain, such as toothache, headache, neuralgia, muscle aches and dysmenorrhea. It is also used to reduce fever in fever diseases such as colds and influenza, treat rheumatic pain, etc. It can prevent thrombosis and is clinically used to prevent transient ischemic attacks, myocardial infarction, artificial heart valves, and venous fistulas or other post-operative thrombosis. At present, studies have shown that aspirin can also prevent colon cancer. However, long-term direct contact of ordinary aspirin tablets with the gastrointestinal tract can cause gastric mucosal erosion, bleeding and ulcers, greatly increasing the risk of long-term users suffering from ulcer disease. Ulcers can damage the colon, leading to changes in colon structure and morphology. Long-term ulcers can easily cause dysplasia and induce colon cancer. Summary of the invention

[0005] In view of this, the present invention provides a multifunctional targeted capsule using resistant starch as the wall material, which reduces the incidence of ulcers and colon cancer caused by direct contact of aspirin with the gastrointestinal tract.

[0006] In view of this, the present invention provides a multifunctional targeted capsule with resistant starch as the wall material, wherein the capsule wall material is butyrylated resistant starch and the core material is aspirin;

[0007] The preparation of the capsule comprises the following steps: preparing sol: taking 10 parts of butyrylated resistant starch, putting the butyrylated resistant starch into 10 parts of ethanol solution, adding 2-4 parts of plasticizer, 1.2-2.8 parts of gelling agent, 0.1-0.3 parts of coagulant and 70-90 parts of deionized water, stirring and mixing evenly, maintaining the temperature at 60-95° C., and sol for 1-3 hours;

[0008] After the sol is finished, keep it at 55--65℃ for 1-3h to degas the glue;

[0009] Dipping in glue to make capsule blanks: Select a capsule mold of suitable size, apply a release agent on the surface of the capsule mold, dip in glue once at a temperature of 48-65°C to prepare enteric-coated capsule blanks, and turn them over several times at room temperature to dry and shape them;

[0010] Drying and shelling: The capsule embryos are dried in a ventilation tunnel at room temperature and a defined humidity for 1.5-3 hours, and then shelled, trimmed, and assembled to obtain the multifunctional targeted capsules.

[0011] The beneficial effect is that the butyrylated resistant starch itself has strong hydrophobicity and cannot be dissolved when directly mixed with water. The butyrylated resistant starch floats on the water surface and cannot form a uniform mixed solution, nor can it be used as a wall material raw material to prepare capsules. In the present invention, an ethanol solution is introduced, and through a comparative experiment, the butyrylated resistant starch is first mixed with the ethanol solution, the butyrylated resistant starch sinks to the bottom of the ethanol solution, and then water is added and stirred to form a uniform emulsion, so that the butyrylated resistant starch can be smoothly used as a wall material raw material for preparing capsules.

[0012] The invention provides a multifunctional targeted capsule with resistant starch as the wall material. Compared with the prior art, the invention has the advantages that butyrylated starch is a specific starch containing high-amylose, namely resistant starch. The multifunctional targeted capsule prepared by using butyrylated resistant starch belongs to a real plant-type enteric-coated capsule, which can completely get rid of the dependence of hollow capsules on animal-derived raw materials. Moreover, butyrylated resistant starch will not be digested and dissolved in the stomach, so aspirin is prevented from directly contacting the stomach, and the side effects of aspirin can be effectively reduced, and the incidence of ulcer disease can be reduced. After the butyrylated starch is decomposed and ingested in the colon part, the short-chain fatty acids in the human intestine are increased, especially the release of butyric acid is specifically increased, so the incidence of colon cancer can be reduced. Moreover, after the butyrylated resistant starch is decomposed, the number of beneficial bacteria in the intestine is increased, the pH in the intestine is reduced, and the flora in the intestine is balanced. At this time, the medicinal effect of aspirin itself can also act on the human body.

[0013] Optionally, the plasticizer is one or more of glycerol, propylene glycol and polyethylene glycol.

[0014] Optionally, the gelling agent is one or two of K carrageenan, pectin and gellan gum.

[0015] Optionally, the coagulant aid is potassium chloride.

[0016] Optionally, the release agent is one or more of salad oil, peanut oil, soybean oil and rapeseed oil.

[0017] Optionally, the room temperature is 25-35°C, and the limited humidity is 35-50%.

[0018] To achieve the above object, the present invention also provides a method for preparing butyrylated resistant starch, comprising the following steps:

[0019] (1) The starch raw material is mixed with water to obtain a 25-35% starch emulsion;

[0020] (2) Use sodium hydroxide solution to adjust the pH to 8-9 and maintain the temperature at 30-50°C;

[0021] (3) Under the condition of 30-50℃ magnetic stirrer, add butyric anhydride dropwise every 0.5h and continue the reaction for 2-3h;

[0022] (4) terminating the reaction by adjusting the pH of the mixture to 5.9-6.5 with a hydrochloric acid solution;

[0023] (5) The mixture is washed, dried at 30-50°C, and then ground through a 100-mesh sieve to obtain butyrylated resistant starch.

[0024] Optionally, the mass ratio of starch:butyric anhydride is 1:1.

[0025] Optionally, the concentration of the sodium hydroxide solution is 1 mol / L; the concentration of the hydrochloric acid solution is 1 mol / L.

[0026] Optionally, the starch raw material includes any one or more of corn starch, waxy corn starch, potato starch, tapioca starch, wheat starch, rice starch, high-amylose corn starch, mung bean starch, pea starch, etc.

[0027] The above technical solution of the present invention includes at least the following beneficial effects:

[0028] In the multifunctional targeted capsule provided by the present invention, aspirin is delivered to the intestine in the form of enteric-coated capsules to exert its medicinal effect, thereby avoiding damage to the stomach; resistant starch can target the intestine to exert a probiotic effect, reduce the pH value of the intestine, and reshape the intestinal flora; uniquely, butyrylated resistant starch is used as a wall material to specifically release more butyric acid, thereby exerting a role in preventing colon cancer; therefore, the present invention uses butyrylated resistant starch to create a multifunctional targeted capsule encapsulating aspirin, thereby achieving three effects at one stroke. DETAILED DESCRIPTION

[0029] In order to make the purpose, technical solution and advantages of the embodiment of the present invention clearer, the technical solution of the embodiment of the present invention will be clearly and completely described in combination with the embodiment of the present invention. Obviously, the described embodiment is a part of the embodiment of the present invention, not all the embodiments. Based on the described embodiment of the present invention, all other embodiments obtained by ordinary technicians in this field belong to the scope of protection of the present invention.

[0030] Example 1

[0031] Preparation of multifunctional targeting capsules

[0032] Ingredients and sol: Take 10 parts of butyrylated resistant starch, put the butyrylated resistant starch into 10 parts of ethanol solution, then add 2 parts of glycerol, 1.2 parts of carrageenan, 0.1 parts of potassium chloride and 70 parts of deionized water, stir and mix evenly, maintain the temperature at 60°C, and sol for 1 hour.

[0033] Curing and degassing of the glue: After the sol is completed, keep it at 55℃ for 1h to degas the glue.

[0034] Dipping in glue to make capsule blanks: Select a capsule mold of suitable size, apply a release agent on the surface of the capsule mold, dip in glue once at 48°C to prepare enteric-coated capsule blanks, and turn them over several times at room temperature to dry and shape them.

[0035] Drying and shelling: Dry the capsule embryos in a ventilation tunnel at room temperature and a certain humidity for 1.5 hours, then shell, trim and assemble to obtain the multifunctional targeting capsules.

[0036] Preparation of butyrylated resistant starch:

[0037] Corn starch was mixed with water to obtain a 25% starch emulsion, and the pH was adjusted to 8 using sodium hydroxide. The temperature was maintained at 30°C. Under the condition of a magnetic stirrer at 30°C, butyric anhydride with the same mass as the corn starch was added dropwise every 0.5 h and the reaction was continued for 2 h. The reaction was terminated by adjusting the pH of the mixture to 5.9 with a hydrochloric acid solution. The mixture was washed, dried at 30°C, and then ground through a 100-mesh sieve.

[0038] Example 2

[0039] Preparation of multifunctional targeting capsules

[0040] Ingredients and sol: Take 10 parts of butyrylated resistant starch, put the butyrylated resistant starch into 10 parts of ethanol solution, then add 4 parts of glycerol, 2.8 parts of carrageenan, 0.3 parts of potassium chloride and 90 parts of deionized water, stir and mix evenly, maintain the temperature at 95°C, and sol for 3 hours.

[0041] Curing and degassing of glue: After the sol is completed, keep it at 65℃ for 3 hours to degas the glue.

[0042] Dipping in glue to make capsule blanks: Select a capsule mold of suitable size, apply a release agent on the surface of the capsule mold, dip in glue once at 65°C to prepare enteric-coated capsule blanks, and turn them over several times at room temperature to dry and shape them.

[0043] Drying and shelling: Dry the capsule embryos in a ventilation tunnel at room temperature and a certain humidity for 3 hours, then shell, trim and assemble to obtain the multifunctional targeted capsules.

[0044] Preparation of butyrylated resistant starch:

[0045] Corn starch was mixed with water to obtain a 35% starch emulsion, and the pH was adjusted to 9 using sodium hydroxide. The temperature was maintained at 50°C. Under the condition of a magnetic stirrer at 50°C, butyric anhydride with the same mass as corn starch was added dropwise every 0.5 h and the reaction was continued for 3 h. The reaction was terminated by adjusting the pH of the mixture to 6.5 using a hydrochloric acid solution. The mixture was washed, dried at 50°C, and then ground through a 100-mesh sieve.

[0046] Example 3

[0047] Preparation of multifunctional targeting capsules

[0048] Ingredients and sol: Take 10 parts of butyrylated resistant starch, put it into 10 parts of ethanol solution, then add 3 parts of glycerol, 2 parts of carrageenan, 0.2 parts of potassium chloride and 80 parts of deionized water, stir and mix evenly, maintain the temperature at 95°C, and sol for 3 hours.

[0049] Curing and degassing of glue: After the sol is completed, keep it at 65℃ for 3 hours to degas the glue.

[0050] Dipping in glue to make capsule blanks: Select a capsule mold of suitable size, apply a release agent on the surface of the capsule mold, dip in glue once at 65°C to prepare enteric-coated capsule blanks, and turn them over several times at room temperature to dry and shape them.

[0051] Drying and shelling: Dry the capsule embryos in a ventilation tunnel at room temperature and a certain humidity for 3 hours, then shell, trim and assemble to obtain the multifunctional targeted capsules.

[0052] Preparation of butyrylated resistant starch:

[0053] Corn starch was mixed with water to obtain a 30% starch emulsion, and the pH was adjusted to 8.5 using sodium hydroxide. The temperature was maintained at 40°C. Under the condition of a magnetic stirrer at 40°C, butyric anhydride with the same mass as the corn starch was added dropwise every 0.5 h and the reaction was continued for 2.5 h. The reaction was terminated by adjusting the pH of the mixture to 6.2 with a hydrochloric acid solution. The mixture was washed, dried at 40°C, and then ground through a 100-mesh sieve.

[0054] Example 4

[0055] The difference compared with Example 3 is that the multifunctional targeting capsule is prepared as follows:

[0056] Ingredients and sol: Take 10 parts of butyrylated resistant starch, put it into 10 parts of ethanol solution, then add 3 parts of glycerol, 2 parts of carrageenan, 0.2 parts of potassium chloride and 75 parts of deionized water, stir and mix evenly, maintain the temperature at 95°C, and sol for 3 hours.

[0057] Curing and degassing of glue: After the sol is completed, keep it at 65℃ for 3 hours to degas the glue.

[0058] Dipping in glue to make capsule blanks: Select a capsule mold of suitable size, apply a release agent on the surface of the capsule mold, dip in glue once at 65°C to prepare enteric-coated capsule blanks, and turn them over several times at room temperature to dry and shape them.

[0059] Drying and shelling: Dry the capsule embryos in a ventilation tunnel at room temperature and a certain humidity for 3 hours, then shell, trim and assemble to obtain the multifunctional targeted capsules.

[0060] Example 5

[0061] The difference compared with Example 3 is that the multifunctional targeting capsule is prepared as follows:

[0062] Ingredients and sol: Take 10 parts of butyrylated resistant starch, put the butyrylated resistant starch into 10 parts of ethanol solution, then add 3 parts of glycerol, 2 parts of carrageenan, 0.2 parts of potassium chloride and 85 parts of deionized water, stir and mix evenly, maintain the temperature at 95°C, and sol for 3 hours.

[0063] Curing and degassing of glue: After the sol is completed, keep it at 65℃ for 3 hours to degas the glue.

[0064] Dipping in glue to make capsule blanks: Select a capsule mold of suitable size, apply a release agent on the surface of the capsule mold, dip in glue once at 65°C to prepare enteric-coated capsule blanks, and turn them over several times at room temperature to dry and shape them.

[0065] Drying and shelling: Dry the capsule embryos in a ventilation tunnel at room temperature and a certain humidity for 3 hours, then shell, trim and assemble to obtain the multifunctional targeted capsules.

[0066] Example 6

[0067] The difference compared with Example 3 is that the multifunctional targeting capsule is prepared as follows:

[0068] Ingredients and sol: Take 10 parts of butyrylated resistant starch, put the butyrylated resistant starch into 10 parts of ethanol solution, then add 3 parts of glycerol, 2 parts of carrageenan, 0.2 parts of potassium chloride and 90 parts of deionized water, stir and mix evenly, maintain the temperature at 95°C, and sol for 3 hours.

[0069] Curing and degassing of glue: After the sol is completed, keep it at 65℃ for 3 hours to degas the glue.

[0070] Dipping in glue to make capsule blanks: Select a capsule mold of suitable size, apply a release agent on the surface of the capsule mold, dip in glue once at 65°C to prepare enteric-coated capsule blanks, and turn them over several times at room temperature to dry and shape them.

[0071] Drying and shelling: Dry the capsule embryos in a ventilation tunnel at room temperature and a certain humidity for 3 hours, then shell, trim and assemble to obtain the multifunctional targeted capsules.

[0072] Comparative Example 1

[0073] The difference compared with Example 3 is that the multifunctional targeting capsule is prepared

[0074] Ingredients and sol: Take 10 parts of ethanol solution and mix it with 80 parts of deionized water, take 10 parts of butyrylated resistant starch, put the butyrylated resistant starch into the mixture, then add 3 parts of glycerol, 2 parts of carrageenan, and 0.2 parts of potassium chloride, stir and mix evenly, maintain the temperature at 95°C, and sol for 3 hours.

[0075] Curing and degassing of glue: After the sol is completed, keep it at 65℃ for 3 hours to degas the glue.

[0076] Dipping in glue to make capsule blanks: Select a capsule mold of suitable size, apply a release agent on the surface of the capsule mold, dip in glue once at 65°C to prepare enteric-coated capsule blanks, and turn them over several times at room temperature to dry and shape them.

[0077] Drying and shelling: Dry the capsule embryos in a ventilation tunnel at room temperature and a certain humidity for 3 hours, then shell, trim and assemble to obtain the multifunctional targeted capsules.

[0078] Comparative Example 2

[0079] The difference compared with Example 3 is that the multifunctional targeting capsule is prepared

[0080] Ingredients and sol: Take 10 parts of butyrylated resistant starch, put it into 10 parts of ethanol solution, then add 3 parts of glycerol, 1.1 parts of carrageenan, 0.2 parts of potassium chloride and 80 parts of deionized water, stir and mix evenly, maintain the temperature at 95°C, and sol for 3 hours.

[0081] Curing and degassing of glue: After the sol is completed, keep it at 65℃ for 3 hours to degas the glue.

[0082] Dipping in glue to make capsule blanks: Select a capsule mold of suitable size, apply a release agent on the surface of the capsule mold, dip in glue once at 65°C to prepare enteric-coated capsule blanks, and turn them over several times at room temperature to dry and shape them.

[0083] Drying and shelling: Dry the capsule embryos in a ventilation tunnel at room temperature and a certain humidity for 3 hours, then shell, trim and assemble to obtain the multifunctional targeted capsules.

[0084] Comparative Example 3

[0085] The difference compared with Example 3 is that the multifunctional targeting capsule is prepared

[0086] Ingredients and sol: Take 10 parts of butyrylated resistant starch, put the butyrylated resistant starch into 10 parts of ethanol solution, then add 3 parts of glycerol, 2.9 parts of carrageenan, 0.2 parts of potassium chloride and 80 parts of deionized water, stir and mix evenly, maintain the temperature at 95°C, and sol for 3 hours.

[0087] Curing and degassing of glue: After the sol is completed, keep it at 65℃ for 3 hours to degas the glue.

[0088] Dipping in glue to make capsule blanks: Select a capsule mold of suitable size, apply a release agent on the surface of the capsule mold, dip in glue once at 65°C to prepare enteric-coated capsule blanks, and turn them over several times at room temperature to dry and shape them.

[0089] Drying and shelling: Dry the capsule embryos in a ventilation tunnel at room temperature and a certain humidity for 3 hours, then shell, trim and assemble to obtain the multifunctional targeted capsules.

[0090] Performance Analysis

[0091] In this test, the multifunctional targeting capsules prepared in Examples 1-6 and Comparative Examples 1-3 were tested for performance, and Table 1 was obtained.

[0092] Simulated gastric fluid

[0093] Take 9 ml of concentrated hydrochloric acid (about 12 mol / L) and dilute it to 1000 ml to prepare dilute hydrochloric acid. Take 16.4 ml of the above hydrochloric acid, add about 800 ml of water and 10 g of pepsin, mix well, add deionized water to dilute to 1000 ml, and set aside.

[0094] Simulated intestinal fluid

[0095] Take 6.8g of potassium dihydrogen phosphate, add 500mL of deionized water to dissolve it, and adjust the pH value of the solution to 6.8 with 0.1mol / L sodium hydroxide solution. Also take 10g of trypsin, add appropriate amount of deionized water to dissolve it, mix the two solutions, and dilute with water to 1000mL for use.

[0096] Test methods

[0097] 0921 Disintegration Time Limit Test Method of Part IV of the Pharmacopoeia of the People's Republic of China

[0098] The instrument device adopts a lifting disintegrator. The lifting disintegrator is used to hang a hanging basket on a bracket through a stainless steel shaft at the upper end, and immersed in a 1000 ml beaker. The position of the hanging basket is adjusted so that when it drops to the lowest point, the screen is 25 mm away from the bottom of the beaker. The beaker is filled with water at a temperature of 37°C ± 1°C. The water level is adjusted so that when the hanging basket rises to the highest point, the screen is 15 mm below the water surface, and the top of the hanging basket is not immersed in the solution. Six capsules prepared in Examples 1, 2, and 3 are taken, first reacted in simulated gastric fluid without a baffle for 2 hours, and the capsule shell of each capsule is detected for cracks or disintegration; then the hanging basket is taken out, washed with a small amount of water, and a baffle is added to each tube. Then, the reaction is changed to simulated intestinal fluid according to the above method to detect whether it can be completely disintegrated within 1 hour.

[0099] The Chinese Pharmacopoeia stipulates that enteric-coated capsules should not disintegrate or crack in gastric juice for 2 hours, and can disintegrate in intestinal juice within 1 hour.

[0100] Table 1 Test results of Examples 1, 2, and 3

[0101]

[0102] According to the analysis in Table 1, the multifunctional targeting capsules prepared in Examples 1-6 meet the requirements of the Chinese Pharmacopoeia (2015 edition) that they are free of cracks and do not disintegrate in gastric juice for 2 hours and can disintegrate in intestinal juice for 1 hour.

[0103] It can be seen from the analysis of Example 3 and Comparative Example 1 that the only difference between them is whether the ethanol solution and deionized water are mixed first. The multifunctional targeted capsules prepared in Comparative Example 1 are not formed. When directly mixed with the ethanol aqueous solution, the butyrylated resistant starch floats in a flocculent state above the solution and cannot be dissolved, and capsules cannot be prepared. However, when the butyrylated resistant starch is mixed with the ethanol solution first, it sinks below the ethanol solution, and then the aqueous solution is added to form a uniform system. Therefore, when preparing multifunctional targeted capsules with butyrylated resistant starch, the ethanol solution must be added first, and then mixed and dissolved with deionized water.

[0104] From the analysis of Example 3 and Comparative Examples 2 and 3, it can be seen that the only difference between them is the content of carrageenan. The multifunctional targeted capsules prepared in Comparative Examples 2 and 3 have high friability and do not meet the requirements of the pharmacopoeia in terms of the disintegration time in simulated gastric fluid. Therefore, too much or too little carrageenan will affect the friability of the capsule and the disintegration time. The multifunctional targeted capsules prepared in Examples 1, 2 and 3 meet the requirements of the pharmacopoeia. Therefore, the present invention selects the number of carrageenan to be 1.2 to 2.8 parts.

[0105] The above are preferred embodiments of the present invention. It should be pointed out that, for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principles of the present invention. These improvements and modifications should also be regarded as within the scope of protection of the present invention.

Claims

1. A multifunctional targeted capsule with resistant starch as wall material, characterized in that: The capsule wall material is butyrylated resistant starch, and the core material is aspirin; the preparation method of the capsule The method comprises the following steps: preparing sol: taking 10 parts of butyrylated resistant starch, putting the butyrylated resistant starch into 10 parts of ethanol solution, adding 2-4 parts of plasticizer, 1.2-2.8 parts of gelling agent, 0.1-0.3 parts of coagulant and 70-90 parts of deionized water, stirring and mixing evenly, maintaining the temperature at 60-95°C, and sol for 1-3 hours; the plasticizer is glycerin; the gelling agent is K carrageenan; the coagulant is potassium chloride; After the sol is finished, keep it at 55~65℃ for 1~3h to degas the glue; Dipping in glue to make capsules: Select a suitable capsule mold, apply a release agent on the surface of the capsule mold, dip in glue once at a temperature of 48-65°C to prepare enteric-coated capsules, and turn them over several times at room temperature to dry and shape them; Drying and shelling: Dry the capsule embryos in a ventilation tunnel at a temperature of 25-35°C and a humidity of 35-50% for 1.5-3 hours, then shell, trim and assemble to obtain the multifunctional targeting capsules; The preparation of the butyrylated resistant starch comprises the following steps: (1) mixing starch raw material with water to obtain 25-35% starch emulsion; (2) Use sodium hydroxide solution to adjust the pH to 8-9 and maintain the temperature at 30-50°C; (3) Under the condition of 30~50℃ magnetic stirrer, add butyric anhydride dropwise every 0.5h and continue the reaction for 2~3h; (4) terminating the reaction by adjusting the pH of the mixture to 5.9 to 6.5 with a hydrochloric acid solution; (5) The mixture is washed, dried at 30-50°C, and then ground through a 100-mesh sieve to obtain butyrylated resistant starch.

2. The multifunctional targeting capsule with resistant starch as the wall material according to claim 1, characterized in that: The release agent is one or a combination of two or more of salad oil, peanut oil, soybean oil and rapeseed oil.

3. The multifunctional targeting capsule with resistant starch as the wall material according to claim 1, characterized in that: The mass ratio of starch to butyric anhydride is 1:

1.

4. The multifunctional targeting capsule with resistant starch as the wall material according to claim 1, characterized in that: The concentration of the sodium hydroxide solution is 1 mol / L; the concentration of the hydrochloric acid solution is 1 mol / L.

5. The multifunctional targeting capsule with resistant starch as the wall material according to claim 1, characterized in that: The starch raw material includes any one or more of corn starch, potato starch, tapioca starch, wheat starch, rice starch, mung bean starch and pea starch.